MedPath

BIO-ZOLMITRIPTAN

BIO-ZOLMITRIPTAN

Approved
DIN Number

02512831

Drug Class

Human

Market Date

Jan 11, 2023

Company
HC

biomed pharma

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02512831
AIG Number0134381001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N02CC03 ZOLMITRIPTAN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:32.28
Health Canada Classification

ACTIVE INGREDIENTS (1)

ZOLMITRIPTANActive
Strength: 2.5 MG
Monograph: ZOLMITRIPTAN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.